11.1 C
Delhi
Saturday, January 17, 2026

All medicines of Sresan Pharmaceuticals banned from sale in Kerala

Health Minister Veena George announced that all medicines manufactured by Sresan Pharmaceuticals, a company based in Kanchipuram, Tamil Nadu, have been banned from distribution and sale in Kerala. The move follows action taken by the Tamil Nadu Drugs Controller to cancel the company’s manufacturing license.

Meanwhile, the Gujarat Drugs Controller has reported that the Respifresh TR syrup (60ml, Batch No. R01GL2523), manufactured by Rednex Pharmaceuticals Pvt. Ltd., Ahmedabad, failed to meet quality standards. In response, the Kerala Drugs Control Department has immediately halted the distribution and sale of this medicine across the state.

The syrup was being distributed by five suppliers in Kerala, who have now been instructed to stop its distribution. Strict action will be taken against anyone found selling the drug. The public has been advised not to use this medicine if they have it in possession.

The minister clarified that these medicines are not supplied through government hospitals. She also directed that strict action be taken against establishments that provide this medicine to children below 12 years without a prescription from a registered doctor.

Earlier Kerala government constituted a committee to submit a report on the management of pediatric cough syrups following the death of at least 14 children after consumption of Coldrif syrup in Madhya Pradesh’s Chhindwara, Kerala Health Minister Veena George said on Tuesday.

Kerala Health Department has also asked the Drugs Controller to issue a notice to pharmacies not to sell pediatric drugs to children without a doctor’s prescription.

Veena George said that the State Drugs Controller has imposed a ban on the particular cough syrup, and the Kerala Medical Services Corporation (KMSCL) does not supply the syrup to government hospitals.

Speaking to ANI, Veena George said, “It’s unfortunate that 16 children died by consuming this cough syrup Coldrif. The Government of India has issued an advisory on the consumption of cough syrup. In Kerala, the Drugs Controller has issued a notification banning the particular cough syrup Coldrif in all the pharmacies across the state.”

“We don’t have this in our essential drugs list. This is not being supplied by the KMSCL, which is our corporation that supplies medicine to government hospitals. But, we are ensuring that the sale is not happening in private hospitals and pharmacies,” the Kerala Minister added.

She said that the committee on pediatric cough syrups will submit its report to the Kerala Government.

“We have already done this in the case of antibiotics and have strict enforcement in the State. We have established a committee that will submit a report to the government. The committee is particularly focused on the management of pediatric cough, because irrelevant combinations should not be in the syrups. We have decided to issue a guideline regarding the management of pediatric cough, which is very essential,” she said.

Furthermore, she alleged that doctors were prescribing cough syrups to children under the age of 2 years, which is not advisable.

Veena George said, “We do have a protocol on the consumption of cough syrup. It is not advisable to give cough syrups to children under 2 years old, but this case shows that doctors are prescribing cough syrups to children under 2 years old, which is unscientific and unacceptable. Kerala Health Department has asked the Drugs Controller to issue a notice to pharmacies not to give pediatric drugs to children without a prescription.”

Add

ET Logo

as a Reliable and Trusted News Source

Google Logo

Add Now!

Latest

UGC Proposes 1 Counsellor per 500 Students, Mental Health Centres in Colleges

New UGC draft mandates mental health centres & a fixed counsellor ratio in all Indian colleges to support student well-being and equitable opportunity.

Delhi Pollution Deaths: Over 9,000 Respiratory Fatalities in 2024

Official data shows a sharp rise in Delhi deaths linked to air pollution. Respiratory diseases caused over 9,000 fatalities as PM2.5 levels surged.

Why Mosquitoes Bite Humans and How We’re Increasing the Threat

Discover how human-driven climate change and habitat loss are making mosquitoes more dangerous and widespread, increasing the risk of deadly diseases.

WHO Backs Ozempic, Mounjaro in First Obesity Treatment Guidelines

The WHO issues first guidelines endorsing GLP-1 drugs for obesity, calling for integrated care and urgent action on global access and equity.

CBD for Dogs: Study Finds Link to Reduced Aggression

New research on 47,000 dogs suggests CBD may calm aggressive behaviour, but experts warn it's not a licensed veterinary medicine.

Topics

Budget 2026: Education Sector Demands Focus on Skills and Jobs

Industry and academia seek higher funding for skill development, NEP implementation, and tax incentives in the upcoming Union Budget to boost employability.

Mumbai Voter Turnout Hits 32-Year High in Lok Sabha Elections

Mumbai recorded 55.38% voter turnout in 2024 Lok Sabha polls, its second-highest in 32 years. Analysis reveals what drove the surge and what it means for the city's civic engagement.

Indian Scientists Uncover Cell’s Life-or-Death Decision Mechanism

Breakthrough research reveals how cells choose survival or self-destruction under stress, opening new paths to treat cancer, heart attacks, and Alzheimer's.

Spirit Release Date: Prabhas & Sandeep Reddy Vanga Film Set for Jan 2026

Sandeep Reddy Vanga announces January 10, 2026, as the release date for his pan-India film Spirit, starring Prabhas and Tripti Dimri.

BJP Breaks Sena Fortress, Wins Historic 2026 BMC Election

The BJP-led Mahayuti alliance ends the Thackeray dynasty's 30-year rule over Mumbai's civic body. Analysis on why Shiv Sena (UBT) crumbled and Congress stalled.

Wipro Declares Rs 6 Dividend as Q3 Profit Dips to Rs 3,119 Crore

Wipro announces Rs 6 per share interim dividend for FY25. Q3 net profit falls to Rs 3,119 crore, but order bookings surge 31% year-on-year.

Bhumi Pednekar’s Daldal Teaser Out, Series Premieres April 5 on Prime

Watch the gritty teaser for crime thriller 'Daldal' starring Bhumi Pednekar as a cop. The series premieres on Amazon Prime Video on April 5.

Doctor’s Viral Senate Testimony: “Biologically, Men Cannot Get Pregnant”

Dr Nisha Verma's exchange with a US senator on pregnancy and gender terminology goes viral, highlighting post-Roe reproductive rights debates.
spot_img

Related Articles

Popular Categories

spot_imgspot_img